<DOC>
	<DOCNO>NCT00355082</DOCNO>
	<brief_summary>This study conduct determine effectiveness lower monotherapy dose lamotrigine currently approve .</brief_summary>
	<brief_title>Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy</brief_title>
	<detailed_description>The study consist Treatment phase , efficacy determine Continuation phase extend safety information . The Continuation phase open Treatment phase participant qualify treatment insufficient number seizure Baseline phase .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Inclusion criterion : Male Female â‰¥13 year age Have confident diagnosis epilepsy partial seizure least 24 week prior Baseline Phase Have document history partial seizure investigator must judge subject likely least 4 partial seizure 8week Baseline Phase . Have experience least 4 partial seizure ( i.e. , simple complex partial seizure without secondary generalization ) 8week ( i.e. , 56 day ) prospective Baseline Phase least one partial seizure occur 4week ( i.e. , 28day ) period . NOTE : With prior authorization GlaxoSmithKline ( GSK ) , retrospective data may take place first 4 week ( i.e. , first 28 day ) Baseline Phase subject provide reliable documentation follow : 1 . A complete daily seizure diary include number , type ( i.e. , simple complex partial seizure without secondary generalization ) , seizure experience day 28 consecutive day immediately prior prospective Baseline Phase 2 . Stability prescribe dosage background antiepileptic drug ( AED ) 3 . Compliance background AED All subject permit use retrospective baseline data must complete minimum four week ( i.e. , 28 day ) prospective Baseline Phase . The retrospective plus prospective Baseline Phases must equal 56 consecutive day prior start dose study drug . currently receive AED monotherapy treatment stable regimen nonenzyme induce AED least four week prior start Baseline Phase . able willing maintain accurate , complete , write daily seizure diary , parent/caregiver able willing maintain accurate , complete , write daily seizure diary entire duration study . able comply dose study drug , background AED , study procedure . understand sign write informed consent , parent legally authorize representative do , prior performance study assessment female , childbearing potential use acceptable form birth control , include one following : 1 . Complete abstinence intercourse two week exposure study drug , throughout clinical trial , period trial account elimination drug ( minimum 2 week ) . 2 . Consistent correct use one follow method birth control : Male partner sterile prior female subject 's entry study sole sexual partner female subject . Any intrauterine device ( IUD ) document failure rate le 1 % per year Double barrier method consist spermicide plus mechanical barrier ( e.g. , spermicide plus male condom female diaphragm ) . NOTE : Women hysterectomy , tubal ligation , postmenopausal consider nonchildbearing potential . NOTE : A pharmacokinetic interaction observe lamotrigine ( LTG ) estrogenbased oral contraceptive . Therefore , use hormonal therapy ( e.g. , contraception hormone replacement therapy ) allow . Exclusion criterion : Exhibits primary generalize seizure ( e.g. , absence , myoclonic primary generalize tonicclonic seizure ) . Has status epilepticus within 24 week prior , , Baseline Phase . Is take enzymeinducing AED ( EIAED e.g . carbamazepine , phenytoin , phenobarbital , primidone ) take 1 background AED . Is currently take lamotrigine ( LTG ) previously adequate trial LTG . Is currently take felbamate Is use hormone therapy Is abuse alcohol and/or substance Has take investigational drug within previous 30 day plan take investigational drug anytime study . Is receive chronic treatment medication could influence seizure control NOTE : Use benzodiazepine allow specified Section 8.1.2 Is currently follow ketogenic diet . Is use vagal nerve stimulation Is plan surgery control seizures study . Is pregnant , breastfeeding , plan become pregnant study within three week last dose study drug . Is suffer acute progressive neurological disease , severe psychiatric disease severe mental abnormality likely interfere objective study . Has clinically significant cardiac , renal , hepatic condition , condition affect absorption , distribution , metabolism excretion drug .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>lamotrigine</keyword>
	<keyword>Lamictal</keyword>
	<keyword>monotherapy</keyword>
</DOC>